|
Volumn 51, Issue 1, 2012, Pages 195-196
|
Wells' syndrome (eosinophilic cellulitis) secondary to infliximab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BIOLOGICAL MARKER;
EMOLLIENT AGENT;
INFLIXIMAB;
PREDNISOLONE;
AGED;
CASE REPORT;
DISEASE DURATION;
DRUG ERUPTION;
EOSINOPHIL COUNT;
EOSINOPHILIA;
ERYTHEMA;
FEMALE;
HISTIOCYTE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LETTER;
LYMPHOCYTIC INFILTRATION;
PRIORITY JOURNAL;
PUNCH BIOPSY;
REMISSION;
RHEUMATOID ARTHRITIS;
SKIN BIOPSY;
SKIN INFLAMMATION;
SKIN PRURITUS;
SWEAT GLAND;
TOPICAL TREATMENT;
TREATMENT DURATION;
WELLS SYNDROME;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
CELLULITIS;
DRUG ERUPTIONS;
EOSINOPHILIA;
FEMALE;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84855166397
PISSN: 14620324
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/ker322 Document Type: Letter |
Times cited : (21)
|
References (9)
|